Age-Related Medicine

Wahlich, John; Orlu, Mine; Mair, Alpana; Stegemann, Sven; van Riet-Nales, Diana

Abstract

A meeting organised by the Academy of Pharmaceutical Sciences focussed on the challenges of developing medicines for older adults. International experts discussed the complexity introduced by polypharmacy and multiple morbidities and how the risk–benefit ratio of a medicine changes as an individual ages. The way in which regulatory authorities are encouraging the development of age-appropriate medicines was highlighted. Examples were provided of the difficulties faced by the older population with some medicinal products and suggestions given as to how the pharmaceutical scientist can build the requirements of the older population into their development of new medicines, as well as improvements to existing ones.

• Journal Article Type: Article
• Acceptance Date: Apr 2, 2019
• Online Publication Date: Apr 9, 2019
• Publication Date: 2019-04
• Deposit Date: May 3, 2021
• Publicly Available Date: May 3, 2021
• Journal: Pharmaceutics
• Publisher: MDPI
• Peer Reviewed: Peer Reviewed
• Volume: 11
• Issue: 4
• Article Number: 172
• DOI: https://doi.org/10.3390/pharmaceutics11040172
• Keywords: polypharmacy; multiple morbidities; ageing; pharmaceutical sciences; product development; SIMPATHY
• Public URL: http://researchrepository.napier.ac.uk/Output/2768781